Literature DB >> 3958961

Characteristics of tolerance, recovery from tolerance and cross-tolerance for cocaine used as a discriminative stimulus.

D M Wood, M W Emmett-Oglesby.   

Abstract

Rats were trained to discriminate an injection of cocaine (10 mg/kg) from saline using a two-lever choice procedure with food as a reinforcer. Subsequently, training was stopped, and cocaine was injected chronically. In one experiment, 10.0 or 20.0 mg/kg/8 hr 8 hr of cocaine for 7 days produced a 2-fold shift to the right of the discriminative stimulus dose-effect curve. A dose of 5.0 mg/kg/8 hr for up to 14 days did not shift the dose-effect curve. In a second experiment, 20 mg/kg/8 hr for 7 or 14 days produced comparable degrees of tolerance. In a third experiment, after termination of 12 days of chronic cocaine injection (20 mg/kg/8 hr), base-line sensitivity to the training stimulus recovered progressively across 18 days. Additional experiments tested the effects of chronic administration of drugs that were substituted (d-amphetamine) or were not substituted (morphine) for the training stimulus. d-Amphetamine (2.5 mg/kg/8 hr for 7 days) produced a 4-fold shift to the right of the dose-effect curve for the detection of both d-amphetamine and cocaine; in contrast, 7 days of escalating morphine doses produced signs of physical dependence but did not alter the sensitivity of rats to the cocaine training stimulus. These results provide evidence that tolerance for cocaine used as a discriminative stimulus occurs as a function of chronic dose, dosing regimen and class of drug administered.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3958961

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

1.  Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine.

Authors:  R L Barrett; J B Appel
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Tolerance to morphine stimulus control: role of morphine maintenance dose.

Authors:  A M Young; C A Sannerud; E S Steigerwald; M D Doty; W J Lipinski; L E Tetrick
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Chronic cocaine enhances defensive behaviour in the laboratory mouse: involvement of D2 dopamine receptors.

Authors:  U Filibeck; S Cabib; C Castellano; S Puglisi-Allegra
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents.

Authors:  Neil E Paterson; Allison Fedolak; Berend Olivier; Taleen Hanania; Afshin Ghavami; Barbara Caldarone
Journal:  Pharmacol Biochem Behav       Date:  2010-03-25       Impact factor: 3.533

5.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984-1987.

Authors:  I P Stolerman; F Rasul; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Environmental modification of tolerance to morphine discriminative stimulus properties in rats.

Authors:  C A Sannerud; A M Young
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  A method to shorten the training phase of drug discrimination.

Authors:  C M Harris; D M Wood; H Lal; M W Emmett-Oglesby
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Tolerance to the reinforcing effects of cocaine in a progressive ratio paradigm.

Authors:  D H Li; R Y Depoortere; M W Emmett-Oglesby
Journal:  Psychopharmacology (Berl)       Date:  1994-11       Impact factor: 4.530

9.  Substitution and cross-tolerance profiles of anorectic drugs in rats trained to detect the discriminative stimulus properties of cocaine.

Authors:  D M Wood; M W Emmett-Oglesby
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

10.  Functional and dispositional tolerance develops during continuous cocaine exposure.

Authors:  E K Johansson; S M Tucker; H B Ginn; B R Martin; M D Aceto
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Apr-Jun       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.